aluates Reports

$ 0.0

Automative

Global Sepsis Treatment Market Research Report 2026

Published Date: 2026-02-26

Report Code: QYRE-Auto-7A9350

Global Sepsis Treatment Market Size Status and Forecast 2022

BUY CHAPTERS

Global Sepsis Treatment Market Research Report 2026

Code: QYRE-Auto-7A9350

Report

2026-02-26

Pages:123

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

NCPC

Bayer

Shanghai Pharmaceuticals

Johnson & Johnson

Novartis

GlaxoSmithKline PLC

TEVA

Mylan NV

Allergan plc

Merck

Asahi Kasei Corporation

AtoxBio

INOTREM

Adrenomed AG

Endacea

Sepsis Treatment Market Size

The global Sepsis Treatment market was valued at US$ 4043 million in 2025 and is anticipated to reach US$ 6327 million by 2032, at a CAGR of 6.7% from 2026 to 2032.

Sepsis Treatment Market

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

Market competition is intense. Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Pfizer accounted for largest market share of about 3% in 2019.

This report delivers a comprehensive overview of the global Sepsis Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sepsis Treatment. The Sepsis Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sepsis Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sepsis Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sepsis Treatment Market Report

Report Metric	Details
Report Name	Sepsis Treatment Market
Accounted market size in 2025	US$ 4043 million
Forecasted market size in 2032	US$ 6327 million
CAGR	6.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Cephalosporin Pencillin Macrolides Others
Segment by Application	Sepsis Severe Sepsis Septic Shock
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline, TEVA, Mylan, Allergan, Merck & Co, Asahi Kasei Corporation, AtoxBio, INOTREM, Adrenomed, Endacea
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sepsis Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Sepsis Treatment Market growing?

Ans: The Sepsis Treatment Market witnessing a CAGR of 6.7% during the forecast period 2026-2032.

What is the Sepsis Treatment Market size in 2032?

Ans: The Sepsis Treatment Market size in 2032 will be US$ 6327 million.

What is the Pfizer share in Sepsis Treatment Market?

Ans: Pfizer accounted for largest market share of about 3% in 2019.

Who are the main players in the Sepsis Treatment Market report?

Ans: The main players in the Sepsis Treatment Market are Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline, TEVA, Mylan, Allergan, Merck & Co, Asahi Kasei Corporation, AtoxBio, INOTREM, Adrenomed, Endacea

What are the Application segmentation covered in the Sepsis Treatment Market report?

Ans: The Applications covered in the Sepsis Treatment Market report are Sepsis, Severe Sepsis, Septic Shock

What are the Type segmentation covered in the Sepsis Treatment Market report?

Ans: The Types covered in the Sepsis Treatment Market report are Cephalosporin, Pencillin, Macrolides, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sepsis Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Cephalosporin

1.2.3 Pencillin

1.2.4 Macrolides

1.2.5 Others

1.3 Market by Application

1.3.1 Global Sepsis Treatment Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Sepsis

1.3.3 Severe Sepsis

1.3.4 Septic Shock

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sepsis Treatment Market Perspective (2021–2032)

2.2 Global Sepsis Treatment Growth Trends by Region

2.2.1 Global Sepsis Treatment Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Sepsis Treatment Historic Market Size by Region (2021–2026)

2.2.3 Sepsis Treatment Forecasted Market Size by Region (2027–2032)

2.3 Sepsis Treatment Market Dynamics

2.3.1 Sepsis Treatment Industry Trends

2.3.2 Sepsis Treatment Market Drivers

2.3.3 Sepsis Treatment Market Challenges

2.3.4 Sepsis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sepsis Treatment Players by Revenue

3.1.1 Global Top Sepsis Treatment Players by Revenue (2021–2026)

3.1.2 Global Sepsis Treatment Revenue Market Share by Players (2021–2026)

3.2 Global Top Sepsis Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Sepsis Treatment Revenue

3.4 Global Sepsis Treatment Market Concentration Ratio

3.4.1 Global Sepsis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sepsis Treatment Revenue in 2025

3.5 Global Key Players of Sepsis Treatment Head Offices and Areas Served

3.6 Global Key Players of Sepsis Treatment, Products and Applications

3.7 Global Key Players of Sepsis Treatment, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Sepsis Treatment Breakdown Data by Type

4.1 Global Sepsis Treatment Historic Market Size by Type (2021–2026)

4.2 Global Sepsis Treatment Forecasted Market Size by Type (2027–2032)

5 Sepsis Treatment Breakdown Data by Application

5.1 Global Sepsis Treatment Historic Market Size by Application (2021–2026)

5.2 Global Sepsis Treatment Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Sepsis Treatment Market Size (2021–2032)

6.2 North America Sepsis Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Sepsis Treatment Market Size by Country (2021–2026)

6.4 North America Sepsis Treatment Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sepsis Treatment Market Size (2021–2032)

7.2 Europe Sepsis Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Sepsis Treatment Market Size by Country (2021–2026)

7.4 Europe Sepsis Treatment Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Sepsis Treatment Market Size (2021–2032)

8.2 Asia-Pacific Sepsis Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Sepsis Treatment Market Size by Region (2021–2026)

8.4 Asia-Pacific Sepsis Treatment Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Sepsis Treatment Market Size (2021–2032)

9.2 Latin America Sepsis Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Sepsis Treatment Market Size by Country (2021–2026)

9.4 Latin America Sepsis Treatment Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sepsis Treatment Market Size (2021–2032)

10.2 Middle East & Africa Sepsis Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Sepsis Treatment Market Size by Country (2021–2026)

10.4 Middle East & Africa Sepsis Treatment Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Sepsis Treatment Introduction

11.1.4 Pfizer Revenue in Sepsis Treatment Business (2021–2026)

11.1.5 Pfizer Recent Development

11.2 NCPC

11.2.1 NCPC Company Details

11.2.2 NCPC Business Overview

11.2.3 NCPC Sepsis Treatment Introduction

11.2.4 NCPC Revenue in Sepsis Treatment Business (2021–2026)

11.2.5 NCPC Recent Development

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Sepsis Treatment Introduction

11.3.4 Bayer Revenue in Sepsis Treatment Business (2021–2026)

11.3.5 Bayer Recent Development

11.4 Shanghai Pharmaceuticals

11.4.1 Shanghai Pharmaceuticals Company Details

11.4.2 Shanghai Pharmaceuticals Business Overview

11.4.3 Shanghai Pharmaceuticals Sepsis Treatment Introduction

11.4.4 Shanghai Pharmaceuticals Revenue in Sepsis Treatment Business (2021–2026)

11.4.5 Shanghai Pharmaceuticals Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Sepsis Treatment Introduction

11.5.4 Johnson & Johnson Revenue in Sepsis Treatment Business (2021–2026)

11.5.5 Johnson & Johnson Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Sepsis Treatment Introduction

11.6.4 Novartis Revenue in Sepsis Treatment Business (2021–2026)

11.6.5 Novartis Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Details

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Sepsis Treatment Introduction

11.7.4 GlaxoSmithKline Revenue in Sepsis Treatment Business (2021–2026)

11.7.5 GlaxoSmithKline Recent Development

11.8 TEVA

11.8.1 TEVA Company Details

11.8.2 TEVA Business Overview

11.8.3 TEVA Sepsis Treatment Introduction

11.8.4 TEVA Revenue in Sepsis Treatment Business (2021–2026)

11.8.5 TEVA Recent Development

11.9 Mylan

11.9.1 Mylan Company Details

11.9.2 Mylan Business Overview

11.9.3 Mylan Sepsis Treatment Introduction

11.9.4 Mylan Revenue in Sepsis Treatment Business (2021–2026)

11.9.5 Mylan Recent Development

11.10 Allergan

11.10.1 Allergan Company Details

11.10.2 Allergan Business Overview

11.10.3 Allergan Sepsis Treatment Introduction

11.10.4 Allergan Revenue in Sepsis Treatment Business (2021–2026)

11.10.5 Allergan Recent Development

11.11 Merck & Co

11.11.1 Merck & Co Company Details

11.11.2 Merck & Co Business Overview

11.11.3 Merck & Co Sepsis Treatment Introduction

11.11.4 Merck & Co Revenue in Sepsis Treatment Business (2021–2026)

11.11.5 Merck & Co Recent Development

11.12 Asahi Kasei Corporation

11.12.1 Asahi Kasei Corporation Company Details

11.12.2 Asahi Kasei Corporation Business Overview

11.12.3 Asahi Kasei Corporation Sepsis Treatment Introduction

11.12.4 Asahi Kasei Corporation Revenue in Sepsis Treatment Business (2021–2026)

11.12.5 Asahi Kasei Corporation Recent Development

11.13 AtoxBio

11.13.1 AtoxBio Company Details

11.13.2 AtoxBio Business Overview

11.13.3 AtoxBio Sepsis Treatment Introduction

11.13.4 AtoxBio Revenue in Sepsis Treatment Business (2021–2026)

11.13.5 AtoxBio Recent Development

11.14 INOTREM

11.14.1 INOTREM Company Details

11.14.2 INOTREM Business Overview

11.14.3 INOTREM Sepsis Treatment Introduction

11.14.4 INOTREM Revenue in Sepsis Treatment Business (2021–2026)

11.14.5 INOTREM Recent Development

11.15 Adrenomed

11.15.1 Adrenomed Company Details

11.15.2 Adrenomed Business Overview

11.15.3 Adrenomed Sepsis Treatment Introduction

11.15.4 Adrenomed Revenue in Sepsis Treatment Business (2021–2026)

11.15.5 Adrenomed Recent Development

11.16 Endacea

11.16.1 Endacea Company Details

11.16.2 Endacea Business Overview

11.16.3 Endacea Sepsis Treatment Introduction

11.16.4 Endacea Revenue in Sepsis Treatment Business (2021–2026)

11.16.5 Endacea Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

NCPC

Bayer

Shanghai Pharmaceuticals

Johnson & Johnson

Novartis

GlaxoSmithKline PLC

TEVA

Mylan NV

Allergan plc

Merck

Asahi Kasei Corporation

AtoxBio

INOTREM

Adrenomed AG

Endacea

List of Tables

Table 1. Global Sepsis Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Cephalosporin

Table 3. Key Players of Pencillin

Table 4. Key Players of Macrolides

Table 5. Key Players of Others

Table 6. Global Sepsis Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Sepsis Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Sepsis Treatment Market Size by Region (US$ Million), 2021–2026

Table 9. Global Sepsis Treatment Market Share by Region (2021–2026)

Table 10. Global Sepsis Treatment Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Sepsis Treatment Market Share by Region (2027–2032)

Table 12. Sepsis Treatment Market Trends

Table 13. Sepsis Treatment Market Drivers

Table 14. Sepsis Treatment Market Challenges

Table 15. Sepsis Treatment Market Restraints

Table 16. Global Sepsis Treatment Revenue by Players (US$ Million), 2021–2026

Table 17. Global Sepsis Treatment Market Share by Players (2021–2026)

Table 18. Global Top Sepsis Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sepsis Treatment Revenue, 2025

Table 19. Ranking of Global Top Sepsis Treatment Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Sepsis Treatment Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Sepsis Treatment, Headquarters and Area Served

Table 22. Global Key Players of Sepsis Treatment, Products and Applications

Table 23. Global Key Players of Sepsis Treatment, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Sepsis Treatment Market Size by Type (US$ Million), 2021–2026

Table 26. Global Sepsis Treatment Revenue Market Share by Type (2021–2026)

Table 27. Global Sepsis Treatment Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Sepsis Treatment Revenue Market Share by Type (2027–2032)

Table 29. Global Sepsis Treatment Market Size by Application (US$ Million), 2021–2026

Table 30. Global Sepsis Treatment Revenue Market Share by Application (2021–2026)

Table 31. Global Sepsis Treatment Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Sepsis Treatment Revenue Market Share by Application (2027–2032)

Table 33. North America Sepsis Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Sepsis Treatment Market Size by Country (US$ Million), 2021–2026

Table 35. North America Sepsis Treatment Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Sepsis Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Sepsis Treatment Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Sepsis Treatment Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Sepsis Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Sepsis Treatment Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Sepsis Treatment Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Sepsis Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Sepsis Treatment Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Sepsis Treatment Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Sepsis Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Sepsis Treatment Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Sepsis Treatment Market Size by Country (US$ Million), 2027–2032

Table 48. Pfizer Company Details

Table 49. Pfizer Business Overview

Table 50. Pfizer Sepsis Treatment Product

Table 51. Pfizer Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 52. Pfizer Recent Development

Table 53. NCPC Company Details

Table 54. NCPC Business Overview

Table 55. NCPC Sepsis Treatment Product

Table 56. NCPC Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 57. NCPC Recent Development

Table 58. Bayer Company Details

Table 59. Bayer Business Overview

Table 60. Bayer Sepsis Treatment Product

Table 61. Bayer Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 62. Bayer Recent Development

Table 63. Shanghai Pharmaceuticals Company Details

Table 64. Shanghai Pharmaceuticals Business Overview

Table 65. Shanghai Pharmaceuticals Sepsis Treatment Product

Table 66. Shanghai Pharmaceuticals Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 67. Shanghai Pharmaceuticals Recent Development

Table 68. Johnson & Johnson Company Details

Table 69. Johnson & Johnson Business Overview

Table 70. Johnson & Johnson Sepsis Treatment Product

Table 71. Johnson & Johnson Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 72. Johnson & Johnson Recent Development

Table 73. Novartis Company Details

Table 74. Novartis Business Overview

Table 75. Novartis Sepsis Treatment Product

Table 76. Novartis Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 77. Novartis Recent Development

Table 78. GlaxoSmithKline Company Details

Table 79. GlaxoSmithKline Business Overview

Table 80. GlaxoSmithKline Sepsis Treatment Product

Table 81. GlaxoSmithKline Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 82. GlaxoSmithKline Recent Development

Table 83. TEVA Company Details

Table 84. TEVA Business Overview

Table 85. TEVA Sepsis Treatment Product

Table 86. TEVA Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 87. TEVA Recent Development

Table 88. Mylan Company Details

Table 89. Mylan Business Overview

Table 90. Mylan Sepsis Treatment Product

Table 91. Mylan Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 92. Mylan Recent Development

Table 93. Allergan Company Details

Table 94. Allergan Business Overview

Table 95. Allergan Sepsis Treatment Product

Table 96. Allergan Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 97. Allergan Recent Development

Table 98. Merck & Co Company Details

Table 99. Merck & Co Business Overview

Table 100. Merck & Co Sepsis Treatment Product

Table 101. Merck & Co Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 102. Merck & Co Recent Development

Table 103. Asahi Kasei Corporation Company Details

Table 104. Asahi Kasei Corporation Business Overview

Table 105. Asahi Kasei Corporation Sepsis Treatment Product

Table 106. Asahi Kasei Corporation Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 107. Asahi Kasei Corporation Recent Development

Table 108. AtoxBio Company Details

Table 109. AtoxBio Business Overview

Table 110. AtoxBio Sepsis Treatment Product

Table 111. AtoxBio Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 112. AtoxBio Recent Development

Table 113. INOTREM Company Details

Table 114. INOTREM Business Overview

Table 115. INOTREM Sepsis Treatment Product

Table 116. INOTREM Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 117. INOTREM Recent Development

Table 118. Adrenomed Company Details

Table 119. Adrenomed Business Overview

Table 120. Adrenomed Sepsis Treatment Product

Table 121. Adrenomed Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 122. Adrenomed Recent Development

Table 123. Endacea Company Details

Table 124. Endacea Business Overview

Table 125. Endacea Sepsis Treatment Product

Table 126. Endacea Revenue in Sepsis Treatment Business (US$ Million), 2021–2026

Table 127. Endacea Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Sepsis Treatment Picture

Figure 2. Global Sepsis Treatment Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Sepsis Treatment Market Share by Type: 2025 vs 2032

Figure 4. Cephalosporin Features

Figure 5. Pencillin Features

Figure 6. Macrolides Features

Figure 7. Others Features

Figure 8. Global Sepsis Treatment Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Sepsis Treatment Market Share by Application: 2025 vs 2032

Figure 10. Sepsis Case Studies

Figure 11. Severe Sepsis Case Studies

Figure 12. Septic Shock Case Studies

Figure 13. Sepsis Treatment Report Years Considered

Figure 14. Global Sepsis Treatment Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Sepsis Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Sepsis Treatment Market Share by Region: 2025 vs 2032

Figure 17. Global Sepsis Treatment Market Share by Players in 2025

Figure 18. Global Sepsis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Sepsis Treatment Revenue in 2025

Figure 20. North America Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Sepsis Treatment Market Share by Country (2021–2032)

Figure 22. United States Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Sepsis Treatment Market Share by Country (2021–2032)

Figure 26. Germany Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Sepsis Treatment Market Share by Region (2021–2032)

Figure 34. China Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Sepsis Treatment Market Share by Country (2021–2032)

Figure 42. Mexico Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Sepsis Treatment Market Share by Country (2021–2032)

Figure 46. Israel Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Sepsis Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Pfizer Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 50. NCPC Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 51. Bayer Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 52. Shanghai Pharmaceuticals Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 53. Johnson & Johnson Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 54. Novartis Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 55. GlaxoSmithKline Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 56. TEVA Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 57. Mylan Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 58. Allergan Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 59. Merck & Co Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 60. Asahi Kasei Corporation Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 61. AtoxBio Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 62. INOTREM Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 63. Adrenomed Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 64. Endacea Revenue Growth Rate in Sepsis Treatment Business (2021–2026)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Sepsis Therapeutics Industry Research Report

Sepsis Drug Market

Sepsis Partnering Market

Septicemia Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sepsis Treatment Drugs Market Research Report 2025

Global Septic Shock Therapeutics Market Research Report 2024

Hemodialyzer and Hemoperfusion Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Wound and Skin Infection Treatment Market Insights Forecast to 2030

Infective Endocarditis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sepsis Biomarkers Market

Kidney Blood Purification Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CRRT and Hemodialysis Machine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Purification System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Extracorporeal Blood Purification Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Purification Equipment Market Insights Forecast to 2030

Global Haemofilters Market Insights Forecast to 2030

Blood Purification Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Crystalloid Intravenous Fluids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Purification Machine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions